In vivo eradication of an established human melanoma by an in vitro generated autologous cytotoxic T cell clone: A scid mouse model

International Journal of Cancer

Volumn 77, Issue 3, 1998, Pages 476-480

  Stenholm, Anna Catharina Olsen ^a   Kirkin, Alexei F ^a   Zeuthen, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER REGRESSION; CANCER RESISTANCE; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MELANOMA; MOLECULAR RECOGNITION; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANIMALS; CELL DIVISION; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE TRANSFUSION; MELANOMA; MICE; MICE, SCID; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031863632     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980729)77:3<476::AID-IJC27>3.0.CO;2-4     Document Type: Article

References (17)

1. ABONOUR, R., CIGEL, F.K., SCHELL, K., BARNSTABLE, C.S., SABATINI, L.M. and MALROVSKA, V., Survival and tissue distribution of human T cell clones in scid mice. J. Immunther., 18, 10-18 (1995).
2. BECKER, J.C., BRABLETZ, T., CZERNY, C., TERMEER, C. and BRÖCKER, E.-B., Tumor escape mechanisms from immuno-surveillance. Int. Immunol., 5, 1501-1508 (1993).
3. COULIE, P.G., VAN DEN EYNDE, B.J., VAN DER BRUGGEN, P., VAN PEL, A. and BOON, T., Antigens recognized by T-lymphocytes on human tumors. Biochem. Soc. Trans., 25, 544-548 (1997).
4. CROWLEY, N.J., VERVAERT, C.E. and SEIGLER, H.F., Human xenugraft nude mouse model of adoptive immunotherapy with human melanoma specific cytotoxic T cells. Cancer Res., 52, 394-399 (1992).
5. GREENBERG, P.D., KERN. D.E., JENSEN, M.C.V., KLARNET, J.P. and CHEEVER, M.A., Effector mechanisms by which adoptively transferred T cells promote tumor eradication. In: R.L. Truitt, R.P. Gale and M.M. Bortin (eds.), Cellular immnotherapy of cancer, pp. 127-135 Alan R. Liss, New York (1987).
6. KAST, W.M., OFFRINGA, R., PETERS, P.J., VOORDOUW, A.C., MELOEN, R.H., VAN DER EB, A.J. and MELIEF, C.J.M., Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell, 59, 603-614 (1989).
7. KIRKIN, A.F., PETERSEN, T.R., OLSEN, A.C., LI, L., THOR STRATEN, P. and ZEUTHEN, J., Generation of human melanoma specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother., 41, 71-81 (1995).
8. KUROSAWA, S., HARADA, M., MATZUSAKI, G., SHINOMIYA. Y., TERAO, H., KOBAYASHI, N. and NOMOTO, K., Early appearing tumour infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology, 85, 338-346 (1995).
9. MULÉ, J.J., JICHA, D.L., AEBERSOLD, P.M., TRAVIS, W.D. and ROSENBERG, S.A., Disseminated human malignant melanoma in congenically immune deficient (bg/nu/xid) mice. J. nat. Cancer Inst., 83, 350-355 (1991).
10. OLSEN, A.C., FOSSUM, B., KIRKIN, A., ZEUTHEN, J. and GAUDERNACK, G., A human melanoma cell line, recognized by both HLA class 1 and class II restricted T cells, is capable of initiating both primary and secondary immune responses. Scand. J. Immunol., 41, 357-364 (1995).
11. + T-cells in severe combined immunodeficiency (scid) mice. Int. Immunol., 3, 657-663 (1991).
12. ROSENBERG, S.A., Adoptive immunotherapy for cancer. Sci. Amer, 262, 34-41 (1990).
13. ROSENBERG, S.A., Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today, 18, 175-182 (1997).
14. ROSENBERG, S.A. and 15 OTHERS, Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanomas N. Engl. J. Med., 319, 1676-1680 (1988).
15. SABZEVARI, H. and REISFELD, R.A., Human cytptoxic T cells suppress the growth of spontaneous melanoma metastasis in SCID/hu mice. Cancer Res., 53, 4933-4937 (1993).
16. SHPITZ, B., FERNANDES, B.J., MULLEN, B.M., RODER, J.C. and GALLINGER, S., Improved engraftment of human tumors in SCID mice pretreated with radiation and anti-asialo GM1. Anticancer Res., 14, 1927-1934 (1994).
17. VAN DEN EYNDE, B.J. and BOON, T., Tumor antigens recognized by T lymphocytes. Int. J. clin. Lab. Res., 27, 81-86 (1997).